Sleeve gastrectomy, widely known as gastric sleeve surgery, is one of the most frequently performed bariatric procedures used in the surgical management of obesity and obesity-related metabolic disease. It is considered for individuals who meet internationally defined eligibility criteria and who have not achieved adequate results with diet, exercise, and medical therapy. The operation is based on the permanent removal of a large portion of the stomach, and the overall care pathway extends well beyond the operation itself: candidate assessment, surgical technique, early recovery, and lifelong nutritional and vitamin monitoring all form part of a structured programme. This page reviews the clinically relevant aspects of gastric sleeve surgery from the perspective of the General Surgery Department at Koru Hospital in Ankara, with international patients in mind.
What Is Sleeve Gastrectomy and How Is It Defined?
Sleeve gastrectomy is the surgical removal of the greater part of the stomach so that the remaining organ takes the shape of a narrow tube, or "sleeve." During the procedure, approximately 70 to 80 percent of the stomach — the portion running along the greater curvature, its outer curve — is permanently removed. What remains is a banana-shaped stomach with a markedly reduced capacity: from roughly 1,500–2,000 millilitres before surgery down to about 100–150 millilitres. This smaller stomach physically limits the amount of food that can be eaten at one time and, just as importantly, triggers significant hormonal changes.
Historically, sleeve gastrectomy was first described as the initial stage of a more extensive bariatric operation called biliopancreatic diversion with duodenal switch (BPD/DS). Over time, it became clear that this first stage alone produced substantial weight loss and metabolic improvement, and the procedure spread worldwide as a stand-alone operation. Data from IFSO (the International Federation for the Surgery of Obesity and Metabolic Disorders) show that sleeve gastrectomy has become the most commonly chosen bariatric procedure globally over the past decade, and the ASMBS (American Society for Metabolic and Bariatric Surgery) recognises it as an evidence-based, well-established option.
In medical terms, sleeve gastrectomy is classified as both a restrictive and a hormonally active procedure. Removing the upper part of the stomach, known as the fundus, sharply reduces the secretion of ghrelin — often called the "hunger hormone." The operation is therefore not simply a reduction in stomach volume; it is a surgical intervention that influences appetite regulation and metabolic balance, which is why it is discussed under the broader heading of metabolic surgery. In advanced obesity, it is used not only as a weight-loss tool but also as part of the management of associated conditions such as type 2 diabetes, hypertension, obstructive sleep apnoea, insulin resistance, and dyslipidaemia.
How Does Gastric Sleeve Surgery Work?
The effect of gastric sleeve surgery rests on two main pillars: physical restriction and hormonal regulation. Restriction results from the substantial reduction in stomach capacity. After surgery, patients feel full with far smaller amounts of food, and smaller portions translate into a marked drop in daily calorie intake. The narrowed, tube-shaped stomach also changes gastric emptying: food passes into the small intestine more quickly, which activates satiety signals earlier in the meal.
The hormonal component is among the most important metabolic effects of the operation. The removed fundus produces most of the body's ghrelin, and ghrelin levels fall markedly after surgery. Patients typically report less hunger, fewer cravings between meals, and easier appetite control. At the same time, the secretion of satiety hormones such as GLP-1 (glucagon-like peptide-1) and PYY (peptide YY) increases. These changes support blood glucose control and produce early favourable effects on type 2 diabetes.
From a metabolic standpoint, studies have shown improved insulin sensitivity and regression of fatty liver disease after the operation. Figures reported by IFSO and the ADA (American Diabetes Association) indicate short-term type 2 diabetes remission rates in the range of 60–80 percent, settling at around 50 percent at five-year follow-up. Excess weight loss (%EWL) over five years is reported on average between 55 and 70 percent. It should be emphasised that outcomes depend not only on the surgical technique but also on sustained changes in diet, regular physical activity, and psychological support after surgery. The mechanism of success is therefore best understood as multidisciplinary rather than purely surgical.
How Does the Gastric Sleeve Differ from Gastric Bypass and Other Bariatric Procedures?
Several distinct techniques exist within bariatric surgery, each with its own mechanism, advantages, and limitations. Sleeve gastrectomy is a restrictive procedure with hormonal effects, whereas Roux-en-Y gastric bypass (RYGB) combines restriction with malabsorption — a deliberate reduction in nutrient absorption. In RYGB, a small gastric pouch is created and connected directly to a segment of the small intestine, bypassing part of the digestive tract so that both food intake and calorie absorption are reduced. The one-anastomosis (mini) gastric bypass, known as OAGB, achieves a similar mechanism with a technically simpler configuration.
The defining feature of the sleeve is that the intestinal tract is left untouched. Digestion follows its natural route and nutrient absorption is largely preserved, which carries a lower long-term risk of vitamin and mineral deficiency than bypass procedures — although monitoring of vitamin B12, vitamin D, iron, and calcium remains necessary. After gastric bypass, deficiencies related to malabsorption are more frequent and usually require more intensive lifelong supplementation. On the other hand, RYGB has been reported to exert a stronger metabolic effect on type 2 diabetes remission and lipid control in some patients.
Biliopancreatic diversion (BPD/DS) is the procedure with the most pronounced malabsorptive effect and is reserved for selected patients with a very high body mass index; it produces substantial weight loss but demands extremely careful nutritional follow-up. Gastro-oesophageal reflux disease (GERD) is another important consideration: in patients with significant reflux, a sleeve gastrectomy is planned with caution, and RYGB may be the more appropriate choice. The final decision is individualised by the bariatric team after weighing body mass index, associated conditions, eating patterns, reflux status, previous abdominal operations, and the patient's own preferences, guided by evidence-based clinical guidelines.
Who Is a Suitable Candidate for Gastric Sleeve Surgery?
Candidate selection is based on international guidelines and a multidisciplinary assessment. The IFSO 2022 criteria and ASMBS recommendations have broadened the indications for bariatric surgery: the decision now takes into account not only BMI (body mass index) but also metabolic status, coexisting diseases, and loss of quality of life. Evaluation is carried out by a team that typically includes a dietitian, an endocrinologist, a psychiatrist, a pulmonologist, and a general surgeon.
As a rule, individuals with a BMI of 40 kg/m² or above are considered direct candidates for bariatric surgery. Those with a BMI between 35 and 40 kg/m² are considered when obesity-related conditions such as type 2 diabetes, hypertension, sleep apnoea, dyslipidaemia, or fatty liver disease are present. In recent guideline updates, patients with a BMI of 30–35 kg/m² and type 2 diabetes that has not responded to medical therapy may also be evaluated for metabolic surgery; in this group the decision is made on an individual basis, with endocrinology input playing a central role.
Assessment goes beyond numbers. A documented history of unsuccessful weight-loss attempts — diet, exercise, behavioural therapy, and medication — strengthens the case for surgery. Eating disorders, uncontrolled binge-eating episodes, untreated psychiatric illness, and a history of substance dependence must be addressed before any operation. Equally important is the patient's ability to commit to long-term follow-up, permanent dietary changes, and regular vitamin supplementation. Careful candidate selection is one of the most decisive factors for both surgical success and long-term outcome.
What BMI and Age Range Apply to Gastric Sleeve Surgery?
BMI is one of the key measurements in the decision-making process. It is calculated by dividing body weight in kilograms by the square of height in metres, and it is used internationally to grade obesity and define surgical indications. IFSO and ASMBS guidelines define a BMI of 40 kg/m² or higher — classically termed morbid obesity — as the primary indication for sleeve gastrectomy; this is the group that benefits most from bariatric surgery.
Patients with a BMI of 35–39.9 kg/m² become candidates when accompanied by conditions such as type 2 diabetes, sleep apnoea, hypertension, dyslipidaemia, insulin resistance, polycystic ovary syndrome, severe joint disease, or fatty liver. For patients with a BMI of 30–34.9 kg/m² and type 2 diabetes refractory to medical treatment, current guidelines clearly describe an indication for metabolic surgery, where the goal is not only weight reduction but surgical improvement of glycaemic control — a position also supported by joint statements from the ADA and EASD (European Association for the Study of Diabetes).
Regarding age, the classical range for sleeve gastrectomy is 18 to 65 years. With advances in anaesthesia and laparoscopic surgery, however, the procedure is now also performed in appropriately selected patients over 65 and in adolescents with severe obesity. In patients below adulthood, the decision is made jointly by paediatric endocrinology and paediatric surgery teams. Age alone is never the deciding factor: biological age, coexisting disease, cardiac reserve, and psychosocial readiness are assessed together, and candidacy is the outcome of a multidimensional clinical evaluation rather than a single numerical threshold.
How Is the BMI Scale Classified?
The BMI scale follows the standard ranges defined by the World Health Organization, covering underweight, normal weight, overweight, obesity, and morbid obesity. A BMI below 18.5 kg/m² is classified as underweight and 18.5–24.9 kg/m² as normal weight; neither group falls within the scope of surgical weight management. A BMI of 25–29.9 kg/m² is classified as overweight, for which lifestyle changes, dietary adjustment, exercise, and — where needed — behavioural therapy are generally recommended.
A BMI of 30–34.9 kg/m² corresponds to Class I obesity. The first-line approach here is medical treatment and lifestyle modification, but metabolic surgery may be considered when conditions such as type 2 diabetes are present and medical therapy has failed. A BMI of 35–39.9 kg/m² defines Class II obesity, an important threshold for bariatric surgery candidacy when comorbidities coexist. Values of 40 kg/m² and above constitute Class III, or morbid, obesity — the group with a direct indication for bariatric surgery.
Two further categories are recognised: super obesity (BMI of 50 kg/m² and above) and super-super obesity (60 kg/m² and above). These groups require different considerations in terms of technique selection, anaesthetic management, and perioperative risk. A single-stage sleeve gastrectomy may be chosen in some cases, while at very high BMI values a two-stage strategy or alternative techniques such as biliopancreatic diversion may be evaluated. BMI alone is not a complete indicator; waist circumference, waist-to-hip ratio, body fat percentage, and the metabolic profile provide a fuller clinical picture. In everyday practice, however, BMI remains the principal reference point in surgical decision-making.
What Is the Appropriate Age Range for Gastric Sleeve Surgery?
The question of age cannot be reduced to a single number. The classical range for sleeve gastrectomy has been 18 to 65 years, but growing clinical experience, refinements in anaesthesia, and progress in laparoscopic surgery have made these limits more flexible. Both adolescents and older adults can now be accepted as candidates after appropriate evaluation.
In adolescents, the decision is made by a team that includes paediatric endocrinology, paediatric surgery, child psychiatry, and a dietitian. Bariatric surgery may be considered for adolescents with a BMI above 40 kg/m², or above 35 kg/m² in the presence of severe comorbidity such as type 2 diabetes, sleep apnoea, or advanced fatty liver disease. Largely completed skeletal growth, a supportive family environment, sufficient maturity, and the ability to adhere to long-term follow-up are decisive factors. International guidelines draw on studies indicating that obesity-related complications can be reversed when addressed early in adolescence.
In patients over 65, the assessment is considerably more detailed. Cardiac reserve, lung function, kidney function, medication use, and existing comorbidities are the main determinants of perioperative risk, and biological age is regarded as more meaningful than chronological age. In appropriately selected patients aged 65–70, sleeve gastrectomy may be considered and can bring a marked improvement in quality of life, although weight loss tends to proceed more slowly than in younger patients and nutritional follow-up must be more meticulous. Above the age of 70, the decision rests entirely on the individual clinical picture. The underlying aim in defining an age range is always the same: identifying the patients who stand to benefit most from surgery while carrying the lowest risk.
When Is Gastric Sleeve Surgery Not Recommended?
Defining who should not undergo the operation is as important as defining who is eligible. Contraindications are grouped as absolute and relative. Absolute contraindications include advanced heart failure, uncontrolled coronary artery disease, severe respiratory failure, advanced liver cirrhosis (particularly with portal hypertension), ongoing active cancer treatment, severe bleeding disorders, and serious untreated psychiatric illness. When any of these is present, surgery is avoided.
Relative contraindications include uncontrolled type 1 diabetes, active peptic ulcer disease, untreated Helicobacter pylori infection, severe gastro-oesophageal reflux disease (GERD), Barrett's oesophagus, alcohol or substance dependence, severe depression, and untreated eating disorders. Once these conditions have been appropriately managed, sleeve gastrectomy can be reconsidered on an individual basis. In advanced reflux disease in particular, gastric bypass may be the more suitable option — a distinction that has a direct bearing on quality of life after surgery.
Bariatric surgery is not performed during pregnancy, and women planning a pregnancy are advised to avoid conceiving for the first 12–18 months after surgery, the period during which weight loss stabilises and nutritional safety is re-established. Preoperative work-up includes endoscopy, upper gastrointestinal evaluation, echocardiography, pulmonary function tests, and a comprehensive biochemical panel. Psychiatric assessment is an important step in predicting long-term adherence. Patients are informed in detail that surgery entails lifelong dietary change, vitamin supplementation, and clinical follow-up, and a complete informed-consent process is both an ethical and a clinical requirement. Careful screening for contraindications is one of the fundamental safeguards of patient well-being and surgical outcome.
How Is Gastric Sleeve Surgery Performed?
In contemporary practice, sleeve gastrectomy is performed almost exclusively by the laparoscopic ("keyhole") approach. Four to six small incisions are made in the abdominal wall, through which specialised instruments and a camera system are introduced. The operation is carried out under general anaesthesia by an experienced bariatric team — surgeon, assistant surgeon, anaesthetist, nurses, and technicians. Before surgery, antibiotic prophylaxis and measures against venous thromboembolism are put in place, including compression stockings and mechanical calf compression.
The operation begins by freeing the ligaments along the greater curvature of the stomach using advanced energy devices (bipolar or ultrasonic instruments). The angle of His and the posterior wall of the stomach are then exposed. The surgeon starts the resection approximately 2–6 centimetres (typically 2–4 centimetres) from the pylorus, the outlet of the stomach. A calibration tube called a bougie — usually 36–40 French in diameter — is passed into the stomach to act as a sizing guide, determining the final width of the sleeve. Guided by the bougie, the stomach is divided and simultaneously sealed with surgical stapling devices, creating the tube-shaped remnant.
Once stapling is complete, the resected portion of the stomach is placed in a retrieval bag and removed from the abdomen. The staple line is inspected for bleeding, and additional sutures may be placed where necessary; in some cases the line is reinforced with seromuscular sutures or biological buttressing material. At the end of the procedure, the integrity of the staple line is verified with a dye or air leak test. Placement of an abdominal drain is optional, and in recent years most centres have moved away from routine drainage. After the port sites are closed, the patient is awakened and transferred to the ward under close observation. Operative time averages 60–120 minutes, with patient-specific anatomy influencing the duration.
What Does the Laparoscopic (Closed) Technique Involve?
Laparoscopic sleeve gastrectomy is a modern application of minimally invasive surgical principles. Instead of a large incision, the operation is performed through small trocars — specialised access cannulas placed through the abdominal wall. Carbon dioxide gas is introduced into the abdomen to create a working space, a step known as pneumoperitoneum. High-resolution camera systems give the surgeon a magnified view of the operative field, allowing vessels and tissue planes to be assessed with great clarity.
Compared with open surgery, the laparoscopic approach offers well-documented advantages: postoperative pain is generally lower, recovery is faster, hospital stay is shorter, and patients return to daily activities sooner. The minimal scarring also supports psychosocial adjustment. Rates of wound infection, incisional hernia, and respiratory complications are considerably reduced. These benefits have made laparoscopy the standard approach in bariatric surgery.
Newer techniques have also found a place in sleeve gastrectomy. Robotic-assisted surgery allows the surgeon to operate from a console with highly precise movements, which can be advantageous in patients with a very high BMI, though it involves higher costs and somewhat longer operating times than conventional laparoscopy. Single-port laparoscopy, performed through one incision at the navel, offers a cosmetic advantage but requires particular technical experience. Whatever the platform, results depend on the experience of the surgical team, appropriate equipment, thorough preoperative preparation, and careful postoperative care. Standardised surgical protocols and ERAS (Enhanced Recovery After Surgery) programmes are evidence-based frameworks shown to support faster recovery.
How Is the Risk of a Staple-Line Leak Reduced? Triple-Row Staplers and Leak Testing
Among the complications of sleeve gastrectomy, a staple-line leak is the most significant. A leak is defined as the escape of gastric contents into the abdominal cavity through the line closed with staples during surgery. The general literature reports leak rates of 1–3 percent; studies show that with modern techniques and advanced stapling devices this figure can fall below 1 percent. Reducing leak risk relies on a layered strategy covering device selection, surgical technique, and intraoperative testing.
The triple-row stapler is a specialised stapling device that places three rows of staples instead of the classic two, providing stronger closure of the staple line. Staple height is matched to tissue thickness, which varies along the stomach: taller staples are used for the thick-walled antrum near the gastric outlet, and shorter staples for the thinner body and fundus. Choosing the stapler appropriate to tissue thickness reduces both bleeding and leak risk, which is why device selection follows standardised guidance.
Leak testing is performed at the end of the operation to confirm the integrity of the staple line. The two most common methods are the methylene blue test — in which dyed fluid is instilled into the stomach through a nasogastric tube while the staple line is inspected for staining — and the air leak test, in which the submerged staple line is observed for bubbles as air is introduced. These tests allow even microscopic leaks to be identified and repaired during the operation itself. In the literature, 30-day mortality is reported at 0.1–0.3 percent and major complication rates at around 5 percent. Postoperatively, venous thromboembolism prophylaxis with low-molecular-weight heparin is given; the risk of deep vein thrombosis and pulmonary embolism is in the range of 0.3–1 percent. Recognised long-term issues include de novo GERD (reflux appearing after surgery) in 15–30 percent of patients, with a potentially increased long-term risk of Barrett's oesophagus in persistent cases. Rarer events include staple-line stricture (1–2 percent, usually managed with endoscopic dilation), portal vein thrombosis (below 1 percent but potentially serious), and infrequent intraoperative splenic injury. Additional protective measures include reinforcement of the staple line with seromuscular sutures, biological buttress material, and fibrin sealants. Applied together, these measures substantially reduce the risk of postoperative leakage.
How Long Does the Operation Take, and How Long Is the Hospital Stay?
Operative time varies with the experience of the surgical team, the patient's anatomy, the degree of intra-abdominal fat, and any previous abdominal surgery. On average the procedure takes 60–120 minutes; in experienced centres, standard cases are usually completed within 60–90 minutes. The operation may take somewhat longer in patients with a very high BMI, an enlarged left liver lobe, or intra-abdominal adhesions. Duration alone, however, does not determine the quality of the outcome — technical precision does.
Length of stay is planned according to postoperative monitoring protocols and the individual clinical course. In standard practice, patients are observed on the day of surgery in an intensive care unit or a closely monitored ward. During the first 24 hours, pain control, fluid and electrolyte balance, pulse, blood pressure, temperature, and breathing are followed closely. On the first postoperative morning, an upper gastrointestinal contrast study may be performed to assess the integrity of the staple line. If no leak is detected, oral fluids are introduced gradually.
The average hospital stay is 2–4 days, and centres applying ERAS protocols can shorten this to 1–2 days. Discharge criteria include tolerance of oral fluids, pain controlled with oral analgesics, absence of fever, and resolution of nausea and vomiting. During the first 48 hours at home, patients are advised to avoid prolonged bed rest, to take frequent short walks, and to continue breathing exercises — measures that help prevent thromboembolism and pulmonary complications. The first follow-up visit is scheduled within 1–2 weeks of surgery, with subsequent reviews at 1, 3, 6, and 12 months and annually thereafter. This structure can also be adapted for patients travelling from abroad, with early follow-up arranged before the return journey and later reviews coordinated remotely or locally. Long-term surveillance is decisive for maintaining weight loss and detecting deficiencies early.
What Does Recovery After Gastric Sleeve Surgery Look Like?
Recovery is planned as a combination of physical healing and adaptation to a new lifestyle. The first week is a critical period for healing of the staple line and resolution of tissue oedema. Patients begin with a liquid-based diet and gradually increase their activity level. Pain is usually controlled with oral analgesics, and the mild pulling sensation of the first days fades steadily. Warning signs such as fever, worsening abdominal pain, a rising heart rate, or unstable blood pressure are treated as possible indicators of a leak and prompt immediate clinical review.
Between the second and fourth weeks, the diet advances from liquids to purées, allowing the stomach to adapt to its new volume while protecting the healing staple line. Soft solid foods follow between weeks four and six, and from around the second month a gradual return to normal solid food begins. Portion size, chewing time, the separation of liquids from solids, and meal planning are all guided by a bariatric dietitian. Patients in office-based work can usually return within 3–4 weeks, while those in physically demanding jobs may need 6–8 weeks.
Physical activity begins with short walks from the very first days. Lifting loads heavier than about 5–10 kilograms is discouraged during the first 2–3 weeks. Walking time is increased from the fourth week, and from the sixth week activities such as swimming, cycling, and light resistance training can be added. Sexual activity typically resumes gradually after the first 2–3 weeks, once the patient feels well and healing has progressed; favourable long-term changes in sexual function after bariatric surgery have been described, reflecting the hormonal and psychosocial effects of weight loss. When recovery is managed jointly by the patient, surgeon, dietitian, psychologist, and physiotherapist, outcomes tend to be more durable and more satisfying for the patient.
How Should the Liquid, Purée, and Solid Diet Stages Be Followed?
Nutrition after sleeve gastrectomy progresses through four defined stages: liquid (weeks 0–2), purée (weeks 2–4), soft solid (weeks 4–6), and normal solid food (from roughly the second month onward). Each stage reflects the healing of the stomach, its adaptation to a smaller volume, and the textures the patient can tolerate. During the first two weeks, the diet consists of sugar-free liquids: low-sugar fruit juices, strained soups, fat-free broths, milk, plain yoghurt drinks, and unsweetened protein-enriched beverages. The aim is a gentle intake that still delivers adequate fluid and protein.
From weeks two to four, foods are blended to a yoghurt-like consistency. Eggs, well-cooked vegetable purées, strained yoghurt, fresh cheese, finely blended red meat or chicken, and well-mashed fish are all appropriate. Protein is the top nutritional priority after bariatric surgery, with a daily target of 60–80 grams; adequate protein supports muscle preservation, wound healing, and the minimisation of hair loss. Fluid intake between meals is essential, but liquids should not be taken with meals — an interval of about 30 minutes between eating and drinking is recommended.
Between weeks four and six, soft solids are introduced: well-cooked vegetables, rice, pasta, softened bread, chicken breast, fish, and meatballs. From around the second month, normal solid foods return, but portion control, thorough chewing, and meal structure remain lifelong habits. Small portions, extended chewing, 4–6 planned meals per day, and dietary variety are important. Highly fatty or sugary foods, carbonated drinks, alcohol, and processed foods are kept to a minimum. The programme is individualised under the guidance of a bariatric dietitian, because long-term success depends as much on nutritional adherence as on the operation itself.
Are Vitamin and Mineral Supplements Necessary After Surgery?
Vitamin and mineral supplementation after sleeve gastrectomy is an indispensable component of long-term health and is continued for life. Although the sleeve does not create malabsorption, the markedly reduced stomach volume, restricted food intake, and decreased hydrochloric acid production all create a risk of deficiency in certain nutrients. Regular supplementation is therefore a standard part of the bariatric follow-up protocol.
Routinely recommended supplements include a multivitamin-mineral complex, vitamin B12, vitamin D, calcium, and iron. Vitamin B12 deficiency can occur after sleeve gastrectomy because production of intrinsic factor declines; it can be replaced with monthly intramuscular injections or daily sublingual preparations. Vitamin D deficiency is common in people with obesity and is essential for calcium absorption; a daily supplement of 1,000–2,000 IU may be recommended, with the dose adjusted according to blood levels. Calcium citrate is the preferred form after bariatric surgery because it is better absorbed. Iron deficiency is more frequent in women of reproductive age and is corrected with oral — or, when needed, intravenous — preparations.
Folic acid, zinc, magnesium, thiamine (vitamin B1), and copper are also monitored. Laboratory testing is more frequent in the first year and then continues with annual checks: blood count, ferritin, B12, vitamin D, calcium, magnesium, zinc, folate, and liver and kidney function are assessed regularly. In women planning pregnancy, folic acid supplementation is managed with particular care before and after surgery. Neglecting supplementation can lead to hair loss, anaemia, deterioration in bone health, neurological symptoms, and general fatigue — which is why the supplement programme plays a defining role in preserving quality of life and overall health after surgery.
What Can Be Done About Loose Skin After Weight Loss?
Rapid, substantial weight loss after gastric sleeve surgery predisposes most patients to some degree of skin laxity, most noticeably over the lower abdomen, inner arms, inner thighs, buttocks, and chest. The extent depends on individual factors: age, skin elasticity, the amount and speed of weight loss, genetic predisposition, previous pregnancies, and sun damage. Younger patients often retain better elasticity and experience less sagging, whereas the picture tends to be more pronounced at older ages.
Several measures can help limit skin laxity. Adequate hydration supports skin elasticity, with 2–2.5 litres of fluid per day as the standard recommendation. Sufficient protein intake helps preserve muscle mass and supports skin structure. Resistance exercise builds muscle in the upper arms, trunk, and legs; this added muscle volume maintains fullness beneath the skin and softens the appearance of sagging. Resistance training started from about the sixth postoperative week under physiotherapist guidance provides clear long-term benefit.
Maintaining the skin's moisture balance through a balanced intake of dietary fats and topical moisturisers is advised. Smoking impairs skin elasticity and stopping is recommended, while sun protection helps preserve collagen integrity. A steady, sustainable pace of weight loss is preferable to an excessively rapid one. Once weight has stabilised — usually from months 12–18 onward — plastic surgery options can be considered for patients with significant residual laxity. Body-contouring procedures such as abdominoplasty (tummy tuck), brachioplasty (arm lift), breast lift, and thigh lift can address permanent sagging. These operations are planned as complements to bariatric surgery, timed after weight stabilisation and tailored to individual need.
Is There a Risk of Regaining Weight After Gastric Sleeve Surgery?
Weight regain is one of the most important determinants of long-term success after bariatric surgery. Published data indicate that 10–30 percent of patients experience meaningful weight regain within five years of sleeve gastrectomy. This is not solely a matter of surgical technique; it reflects the combined influence of patient adherence, eating habits, physical activity, psychosocial factors, and hormonal adaptation. Regain rarely means returning to the preoperative weight — it usually presents as a partial rebound from the lowest weight achieved.
Recognised contributors include drifting away from the recommended eating pattern, loss of meal structure, consumption of calorie-dense liquids (sugary drinks, alcohol, cream-based beverages), grazing and snacking behaviour, lapses in exercise, long-term adaptation of ghrelin levels, and gradual enlargement of the gastric sleeve over time. Psychosocial factors — depression, anxiety, and emotional eating — can accelerate regain, which is why continued psychological support after bariatric surgery is strongly emphasised.
The most effective protection against weight regain is consistent participation in the follow-up programme from the first year onward. When dietitian support, behavioural therapy, regular physical activity, and psychological monitoring are combined, long-term weight control improves markedly. In patients with significant regain, revision surgery can be evaluated: conversion from sleeve gastrectomy to gastric bypass (RYGB or OAGB) or advanced revision procedures such as SADI-S (single-anastomosis duodeno-ileal bypass) may be performed when indicated. Revision surgery carries higher risk than the primary operation and should be undertaken in experienced centres. The General Surgery Department at Koru Hospital in Ankara manages the gastric sleeve pathway on an individual basis, in line with current clinical guidelines and evidence-based practice. Patients — including those travelling from abroad — may contact the department for detailed preoperative assessment, discussion of the most appropriate surgical technique, and planning of a structured long-term follow-up programme.
Disclaimer: The information on this page is provided for general educational purposes and does not replace a medical examination. Diagnosis and treatment are determined individually for each patient. Please consult a qualified physician about your symptoms.
